BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6254570)

  • 1. Purified proenzyme C1r. Some characteristics of its activation and subsequent proteolytic cleavage.
    Arlaud GJ; Villiers CL; Chesne S; Colomb MG
    Biochim Biophys Acta; 1980 Nov; 616(1):116-29. PubMed ID: 6254570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isolation and functional characterization of the proenzyme form of the catalytic domains of human C1r.
    Lacroix MB; Aude CA; Arlaud GJ; Colomb MG
    Biochem J; 1989 Feb; 257(3):885-91. PubMed ID: 2539098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proenzymic C1s associated with catalytic amounts of C1r. Study of the activation process.
    Arlaud GJ; Reboul A; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):227-35. PubMed ID: 303116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluid phase activation of proenzymic C1r purified by affinity chromatography.
    Villiers CL; Duplaa AM; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1982 Jan; 700(1):118-26. PubMed ID: 6275893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational changes of the subunits C1q, C1r and C1s of human complement component C1 demonstrated by 125I labeling.
    Bauer J; Valet G
    Biochim Biophys Acta; 1981 Aug; 670(1):129-33. PubMed ID: 6268178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification of proenzymic and activated human C1s free ofC1r. Effect of calcium and ionic strength on activated C1s.
    Arlaud GJ; Reboul A; Meyer CM; Colomb MG
    Biochim Biophys Acta; 1977 Nov; 485(1):215-25. PubMed ID: 911862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human complement serine-proteinase C1r is down-regulated by a Ca(2+)-dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q.
    Thielens NM; Illy C; Bally IM; Arlaud GJ
    Biochem J; 1994 Jul; 301 ( Pt 2)(Pt 2):509-16. PubMed ID: 8042996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-independent interaction between the first component of human complement, C1, and the outer membrane of Escherichia coli D31 m4.
    Aubert B; Chesne S; Arlaud GJ; Colomb MG
    Biochem J; 1985 Dec; 232(2):513-9. PubMed ID: 3911948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of C1 in native proenzyme form and its use in a quantitative C1 activation test.
    Cooper NR; Ziccardi RJ
    J Immunol; 1977 Nov; 119(5):1664-7. PubMed ID: 915274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biochemical data on C1 intrinsic activation (author's transl)].
    Colomb MG; Bensa JC; Villiers CL; Arlaud GJ
    Ann Immunol (Paris); 1982; 133C(2):155-64. PubMed ID: 6287903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1.
    Chesne S; Villiers CL; Arlaud GJ; Lacroix MB; Colomb MG
    Biochem J; 1982 Jan; 201(1):61-70. PubMed ID: 6282262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous activation of the first component of human complement (C1) by an intramolecular autocatalytic mechanism.
    Ziccardi RJ
    J Immunol; 1982 Jun; 128(6):2500-4. PubMed ID: 6281332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural features of the first component of human complement, C1, as revealed by surface iodination.
    Villiers CL; Chesne S; Lacroix MB; Arlaud GJ; Colomb MG
    Biochem J; 1982 Apr; 203(1):185-91. PubMed ID: 6285892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of C1r by proteolytic cleavage.
    Ziccardi RJ; Cooper NR
    J Immunol; 1976 Feb; 116(2):504-9. PubMed ID: 1249422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of reaction of human C1-inhibitor with the human complement system proteases C1r and C1s.
    Sim RB; Arlaud GJ; Colomb MG
    Biochim Biophys Acta; 1980 Apr; 612(2):433-49. PubMed ID: 6245704
    [No Abstract]   [Full Text] [Related]  

  • 17. C1 activation and dissociation in disease.
    Laurell AB; Mårtensson U; Sjöholm AG
    Immunol Lett; 1987 Feb; 14(3):249-53. PubMed ID: 3032782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of human C1r: Western blot analysis reveals slow and dose-dependent activation.
    Hosoi S; Borsos T
    J Immunol; 1988 Sep; 141(5):1610-4. PubMed ID: 2842400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the activation of the human C1r complement molecule.
    Bauer J; Valet G
    Mol Immunol; 1982 Mar; 19(3):487-95. PubMed ID: 6285181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rapid and efficient method for the purification of the complement subcomponents C1r and C1s in zymogen form using fast protein chromatography.
    Peitsch MC; Kovacsovics TJ; Isliker H
    J Immunol Methods; 1988 Apr; 108(1-2):265-9. PubMed ID: 2832479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.